Vitamin D2 (Ergocalciferol).

Both the hepatic 25-hydroxylase and the renal 1-alpha-hydroxylase are magnesium-dependent, as is the binding protein that carries the metabolites. Ergocalciferol cannot be activated without adequate magnesium.

Active vitamin D raises osteocalcin and matrix Gla protein, and K2 carboxylates them so they can bind calcium. Without K2 the induced proteins stay in their uncarboxylated form.

Calcitriol induces the TRPV6 channel and calbindin that move calcium across the intestinal wall. The vitamin sets how much of a calcium dose is absorbed.

D2 and D3 compete for vitamin D binding protein and for 25-hydroxylase, and the D2 metabolite has a shorter circulating life. Adding D2 on top of D3 can lower measured 25-hydroxyvitamin D3 rather than adding to total status.

The vitamin D receptor must pair with the retinoid X receptor to bind DNA and switch on its target genes. Retinoid supply is part of the machinery ergocalciferol works through.

Ergocalciferol is absorbed in lipid micelles, so a fat carrier or a meal raises how much of the dose enters circulation. A dry dose taken without fat is absorbed less well.

The vitamin D receptor binds DNA through zinc finger domains, so zinc is structural to the receptor itself. Adequate zinc serves the signalling step downstream of activation.

Vitamin K1 feeds the same carboxylase that activates the Gla proteins vitamin D induces, and tissues convert part of it to menaquinone-4. It covers the carboxylation step from a second form.

Calcitriol raises expression of the intestinal sodium-phosphate cotransporter alongside the calcium transport proteins. Bone mineral is calcium phosphate, so both ions have to be available for normal mineralisation. Serum phosphorus is one of the three markers pooled in the human systematic review of ergocalciferol.

Vitamin D is absorbed passively into enterocytes from mixed micelles and leaves in chylomicrons through the lymph. A meal or a capsule carrying fat drives micelle formation. Fish oil is one common way that fat arrives, which is why the two are so often co-formulated.

Lecithin is a phospholipid emulsifier that helps a lipophilic compound disperse into fine droplets rather than sitting as a separate oil phase. Phospholipid is also a structural component of mixed micelles. The rationale is physical chemistry applied in emulsion and liposomal formats rather than a measured absorption figure for ergocalciferol.

Without adequate bile salt output, dietary fat and the fat-soluble vitamins riding in it are poorly emulsified and absorption falls. That dependence is why fat-soluble vitamin status is a standing concern after procedures or conditions that reduce bile delivery. The pairing is a supportive one in that specific context rather than a general absorption booster.

Pancreatic lipase breaks dietary triglyceride into the amphipathic products that, with bile salts, assemble into mixed micelles. Vitamin D partitions into those micelles for uptake. Where fat digestion is limited, fat-soluble vitamin uptake follows it down.

Charcoal binds lipophilic organic compounds indiscriminately, and a fat-soluble vitamin taken at the same time is a plausible target for that binding. The practical response is separating the doses by several hours. This is an interference to design around, not a pairing to build on.

Psyllium forms a viscous gel that interferes with micelle diffusion to the intestinal surface, which is the same mechanism behind its effect on lipid absorption. A fat-soluble vitamin taken in that window can be caught by the same effect. Separating the doses removes the question.

Vitamin D and vitamin E are absorbed through the same lipid-handling steps and are partly handled by the same transport proteins. At ordinary supplement amounts they coexist without a problem, and both are routinely formulated in the same oil base. Very large doses of one fat-soluble vitamin can influence the handling of another, which is a dosing consideration rather than an incompatibility.

Micellar capacity is finite, and carotenoids are bulky lipophilic molecules that occupy it. The competition has been measured most clearly among carotenoids themselves. For vitamin D the reasoning is the shared route rather than a measured reduction.

Small human studies have described higher circulating 25-hydroxyvitamin D with boron supplementation, proposed to work through slower catabolism of the metabolite. The finding is limited and the mechanism is not settled. It is a marker observation in a small literature, not an established interaction.

The active vitamin D metabolite drives the transcellular calcium transport system in the duodenum, which matters most when calcium intake is modest. Calcium carbonate additionally needs gastric acid to dissolve, so it is taken with food. The two considerations are separate and both bear on how a combined product is dosed.